Neumora Therapeutics, Inc. (NMRA) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $103.87M | -63.8% |
| 2024 | $287.06M | -38.8% |
| 2023 | $469.08M | +205.0% |
| 2022 | -$446.85M | -37.4% |
| 2021 | -$325.22M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $103.87M | -63.8% |
| 2024 | $287.06M | -38.8% |
| 2023 | $469.08M | +205.0% |
| 2022 | -$446.85M | -37.4% |
| 2021 | -$325.22M | — |